Related Experiment Video
Updated: May 29, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
[Rational drug use: an economic approach to decision making]
Daniel Marques Mota1, Marcelo Gurgel Carlos da Silva, Elisa Cazue Sudo
1Agência Nacional de Vigilância Sanitaria, Núcleo de Vigilância de Eventos Adversos e Queixas Técnicas, Unidade de Farmacovigilância. SEPN 515, Bloco B, Edifício Omega, 2o andar, Sala 02, Asa Norte. 70770-502 Brasília DF. daniel.mota@anvisa.gov.br
Abstract:
The present article approaches rational drug use (RDU) from the economical point of view. The implementation of RDU implies in costs and involves acquisition of knowledge and behavioral changes of several agents. The difficulties in implementing RDU may be due to shortage problems, information asymmetry, lack of information, uncertain clinical decisions, externalities, time-price, incentives for drug prescribers and dispensers, drug prescriber preferences and marginal utility. Health authorities, among other agencies, must therefore regularize, rationalize and control drug use to minimize inefficiency in pharmaceutical care and to prevent exposing the population to unnecessary health risks.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Analysis of Population Pharmacokinetic Data

